GoodRx Holdings (GDRX) Receivables - Other (2025 - 2026)

GoodRx Holdings (GDRX) reported Receivables - Other of $11.9 million for Q1 2026, little changed sequentially from $11.9 million in Q4 2025.

GoodRx Holdings (GDRX) Receivables - Other (2025 - 2026) Analysis & Trends

GoodRx Holdings (GDRX) has 2 years of Receivables - Other data on file, last reported at $11.9 million in Q1 2026.

For the quarter ending Q1 2026, Receivables - Other changed N/A year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.9 million (changed N/A YoY), and the FY2025 full-year result was $11.9 million, changed N/A from the prior year.
Receivables - Other was little changed at $11.9 million in Q1 2026, from $11.9 million in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $11.9 million in Q4 2025 to a low of $11.9 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	29.34 Bn	22.03 Bn	662.02 Mn
2	BrightSpring Health Services	13.49 Bn	12.59 Bn	482.22 Mn
3	Healthequity	7.96 Bn	7.70 Bn	256.31 Mn
4	10x Genomics	6.17 Bn	5.63 Bn	106.18 Mn
5	Hinge Health	6.02 Bn	5.70 Bn	154.23 Mn
6	MiniMed	4.19 Bn	3.89 Bn	480.00 Mn
7	Waystar Holding	4.14 Bn	4.07 Bn	216.84 Mn
8	Doximity	3.82 Bn	3.08 Bn	125.97 Mn
9	Privia Health	3.10 Bn	2.73 Bn	-
10	GoodRx Holdings	977.32 Mn	741.61 Mn	173.85 Mn

Download Data